Camson Bio Technologies Ltd Financials

Camson Bio Technologies Ltd Financial Statement

Camson Bio Technologies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Jun 2019	Mar 2019	Dec 2018
Revenue	1.19	1.41	3.89
Operating Expense	6.72	15.38	1.24
Net Profit	-7.54	-11.30	-0.65
Net Profit Margin	-633.61	-801.42	-16.71
Earning Per Share	-2.51	-3.77	-0.22
EBIDTA	-5.52	-13.97	2.65
Effective Tax Rate	TBA	-4.22	-21.43

Particulars	Jun 2019
Revenue	1.19
Operating Expense	6.72
Net Profit	-7.54
Net Profit Margin	-633.61
Earning Per Share	-2.51
EBIDTA	-5.52
Effective Tax Rate	TBA

Camson Bio Technologies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2019	Mar 2018	Mar 2017
Total Revenue Annual	4.98	19.31	10.35
Operating Expenses Annual	21.37	19.28	23.56
Operating Profit Annual	-13.19	1.33	-9.28
Interest Annual	1.14	5.36	6.51
Depreciation	6.97	7.19	7.44
Net Profit Annual	-21.90	-11.22	-23.05
Tax Annual	0.59	TBA	-0.17

Particulars	Mar 2019
Total Revenue Annual	4.98
Operating Expenses Annual	21.37
Operating Profit Annual	-13.19
Interest Annual	1.14
Depreciation	6.97
Net Profit Annual	-21.90
Tax Annual	0.59

Camson Bio Technologies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2019	Mar 2018	Mar 2017
Cash Flow at the Beginning	0.09	0.06	0.10
Cash Flow from Operations	TBA	1.83	4.56
Cash Flow from Investing	-0.01	0.73	2.72
Cash Flow from Financing	-0.02	-2.53	-7.33
Cash Flow at the End	0.06	0.09	0.06

Particulars	Mar 2019
Cash Flow at the Beginning	0.09
Cash Flow from Operations	TBA
Cash Flow from Investing	-0.01
Cash Flow from Financing	-0.02
Cash Flow at the End	0.06

Camson Bio Technologies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2019	Mar 2018	Mar 2017
PBDIT Margin (%)	-264.86	6.89	-89.57
PBIT Margin (%)	-404.82	-30.35	-161.45
PBT Margin (%)	-49.60	-24.71	-136.62
Net PROFIT Margin (%)	-439.76	-58.10	-222.71
Return On Networth / Equity (%)	TBA	TBA	TBA
Return On Networth /Employed (%)	TBA	TBA	TBA
Return On Assets (%)	-21.99	-9.30	-15.59
Total Debt / Equity (X)	0.88	0.66	0.51
Asset Turnover Ratio (%)	0.05	0.16	0.07

Particulars	Mar 2019
PBDIT Margin (%)	-264.86
PBIT Margin (%)	-404.82
PBT Margin (%)	-49.60
Net PROFIT Margin (%)	-439.76
Return On Networth / Equity (%)	TBA
Return On Networth /Employed (%)	TBA
Return On Assets (%)	-21.99
Total Debt / Equity (X)	0.88
Asset Turnover Ratio (%)	0.05

Camson Bio Technologies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2019	Mar 2018	Mar 2017
Fixed Assets Annual	81.33	88.30	95.08
Total Current Assets Annual	34.96	46.88	17.11
Non Current Assets Annual	87.15	94.66	129.99
Total Shareholders Funds Annual	44.75	66.66	77.03
Total Assets Annual	122.11	141.54	147.10

Particulars	Mar 2019
Fixed Assets Annual	81.33
Total Current Assets Annual	34.96
Non Current Assets Annual	87.15
Total Shareholders Funds Annual	44.75
Total Assets Annual	122.11

Camson Bio Technologies Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 23, 2024, Camson Bio Technologies Ltd has a market capitalization of 20.76 Cr. Value Research classifies it as a Micro-Cap company.

No, Camson Bio Technologies Ltd is not debt-free with a debt-to-equity ratio of 1.11.

In FY 2023 , Camson Bio Technologies Ltd recorded a total revenue of approximately 4.98 Cr marking a significant milestone in the company's financial performance.

Camson Bio Technologies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.4% annually, respectively..

Camson Bio Technologies Ltd's current PE ratio is -0.95.

Camson Bio Technologies Ltd's ROCE averaged -11.5% from the FY ending March 2017 to 2019, with a median of -13.4%. It peaked at 0.0% in March NaN, reflecting strong capital efficiency over the period..

Camson Bio Technologies Ltd's latest EBIT is Rs. -20.17 Cr, surpassing the average EBIT of Rs. -14.25 Cr over the 5 years..